Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: A prospective study with intraoperative confirmation

Acta Radiologica

Volumn 48, Issue 4, 2007, Pages 369-378

  Rappeport, E D ^a   Loft, A ^a   Berthelsen, A K ^a   Von Der Recke, P ^a   Larsen, P Noergaard ^a   Mogensen, A Mellon ^a   Wettergren, A ^a   Rasmussen, A ^a   Hillingsoe, J ^a   Kirkegaard, P ^a   Thomsen, C ^a  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

Adults; Biliary; Liver; Metastases; MR imaging; PET

Indexed keywords

BIOLOGICAL ORGANS; COMPUTERIZED TOMOGRAPHY; DISEASE CONTROL; HISTOLOGY; IRON OXIDES; MAGNETIC RESONANCE IMAGING; PATIENT TREATMENT;

BILIARY; EXTRAHEPATIC TUMOR; LIVER METASTASES; SUPERPARAMAGNETIC IRON OXIDE (SPIO)-;

POSITRON EMISSION TOMOGRAPHY;

CONTRAST MEDIUM; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; IRON; OXIDE; RADIOPHARMACEUTICAL AGENT; SUPERPARAMAGNETIC IRON OXIDE;

ABDOMINAL TUMOR; ADULT; AGED; ARTICLE; COLON TUMOR; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; IMAGE ENHANCEMENT; LIVER TUMOR; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PERITONEUM TUMOR; POSITRON EMISSION TOMOGRAPHY; PROSPECTIVE STUDY; RECTUM TUMOR; SENSITIVITY AND SPECIFICITY;

ABDOMINAL NEOPLASMS; ADULT; AGED; COLONIC NEOPLASMS; CONTRAST MEDIA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; IRON; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXIDES; PERITONEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RECTAL NEOPLASMS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34247358226     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850701294560     Document Type: Article

References (37)

1. Abdel-Nabi H, Doerr RJ, Lamonica DM, Cronin VR, Galantowicz PJ, Carbone GM, et al. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology 1998;206:755-60.
2. 18F] fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases. J Clin Oncol 2005;23:8713-6.
3. Ba-Ssalamah A, Heinz-Peer G, Schima W, Schibang N, Schick S, Prokesch RW, et al. Detection of focal hepatic lesions: comparison of unenhanced and SHU 555 A-enhanced MR imaging versus biphasic helical CTAP. J Magn Reson Imaging 2000;11:665-72.
4. Berthelsen AK, Holm S, Loft A, Klausen TL, Andersen F, Hojgaard L. PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients. Eur J Nucl Med Mol Imaging 2005;32:1167-75.
5. Bipat S, van Leeuwen MS, Comans EFI, Pijl ME, Killius J, Clavien PA, et al. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis - meta-analysis. Radiology 2005;237:123-31.
6. Blakeborough A, Ward J, Wilson D, Griffith SM, Kajiya Y, Guthrie JA, et al. Hepatic lesion detection at MR imaging: a comparative study with four sequences. Radiology 1997;203:759-65.
7. Blokhuis TJ, van der Schaaf MC, van den Toi MP, Comans EFI, Manoliu RA, van der Sijp JRM. Results of radio frequency ablation of primary and secondary liver tumors: long-term follow-up with computed tomography and positron emission tomography-18F-deoxy-fluoroglucose scanning. Scand J Gastroenterol 2004;39 Suppl 241:93-7.
8. Böhm B, Voth M, Geoghegan J, Hellfritzsch H, Petrovich A, Scheele J, et al. Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors. J Cancer Res Clin Oncol 2004;130:266-72.
9. Cohade C, Osman M, Leal J, Wahl RL. Direct comparison of 18F-FDG-PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 2003;44:1797-803.
10. Delbelke D, Vitola JV, Sandier MP, Arildsen RC, Powers TA, Wright JK Jr, et al. Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 1997;38:1196-201.
11. Flanagan FL, Dehdashti F, Ogunbiyi A, Kodner IJ, Siegel BA. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg 1998;227:319-23.
12. 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg 1999;178:282-7.
13. Furuhata T, Okita K, Tsuruma T, Hata F, Kimua Y, Katsuramaki T, et al. Efficacy of SPIO-MR imaging in the diagnosis of liver metastases from colorectal carcinomas. Dig Surg 2003;20:321-5.
14. Huebner RH, Park KC, Shepherd JE, Schwimmer J, Czernin J, Phelps ME, et al. A meta-analysis of the literature for whole-body PET detection of recurrent colorectal cancer. J Nucl Med 2000;41:1177-89.
15. Imdahl A, Reinhardt MJ, Nitzsche EU, Mix M, Dingeldey A, Einert A, et al. Impact of 18F-FDG-positron emission tomography for decision making in colorectal cancer recurrences. Arch Surg 2000;385:129-34.
16. Kim MJ, Mitchell DG, Ito K, Kim PN. Hepatic MR imaging: comparison of 2D and 3D gradient echo techniques. Abdom Imaging 2001;26:269-76.
17. Kim SH, Choi D, Kim SH, Lim JH, Lee WJ, Kim MJ, et al. Ferucarbotran-enhanced MRI versus triple- phase MDCT for the preoperative detection of hepatocellular carcinoma. Am J Roentgenol 2005;184:1069-76.
18. Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR Imaging, PET): a meta-analysis. Radiology 2002;224:748-56.
19. Kuszyk BS, Bluemke DA, Urban BA, Choti MA, Hruban RH, Sitzmann J, et al. Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors: sensitivity based on comparison with intraoperative and pathologic findings. Am J Roentgenol 1996;166:91-5.
20. 18F] fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. Arch Surg 1996;131:703-7.
21. Numminen K, Isoniemi H, Halavaara J, Tervahartiala P, Makusalo H, Laasonen L, et al. Preoperative assessment of focal liver lesions: multidetector computed tomography challenges magnetic resonance imaging. Acta Radiol 2005;46:9-15.
22. Reimer P, Jähnke N, Fiebich M, Schima W, Deckers F, Marx C, et al. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology 2000;217:152-8.
23. Rohren EM, Paulson EK, Hagge R, Wong TZ, Killius J, Clavien PA, et al. The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer. Clin Nucl Med 2002;27:550-5.
24. Ruers TJM, Langenhoff BS, Neeleman N, Jager GJ, Strijk S, Wobbes T, et al. Value of positron emission tomography with [F-18] fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Oncol 2002;20:388-95.
25. Rydzewski B, Dehdashti F, Gordon BA, Teefey SA, Strasberg SM, Siegel BA. Usefulness of intraoperative sonography for revealing hepatic metastases from colorectal cancer in patients selected for surgery after undergoing FDG PET. Am J Roentgenol 2002;178:353-8.
26. Scott DJ, Guthrie JA, Arnold P, Ward J, Atchley J, Wilson D, et al. Dual phase helical CT versus portal venous phase CT for the detection of colorectal liver metastases; correlation with intra-operative sonography, surgical and pathological finings. Clin Radiol 2001;56:235-42.
27. Selzner M, Hany TF, Wildbrett P, McCormack L, Kadry Z, Clavien PA. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 2004;240:1027-36.
28. Semelka RC, Cance WG, Marcos HB, Mauro MA. Liver metastases: comparison of current MR techniques and spiral CT during arterial portography for detection in 20 surgically staged cases. Radiology 1999;213:86-91.
29. 18F]fluoro-2-deoxyglucose positron emission tomography of resectable colorectal liver metastases. Br J Surg 2005;92:362-9.
30. Valls C, Andía E, Sánchez A, Guma A, Figueres J, Torras J, et al. Hepatic metastases from colorectal cancer: preoperative assessment of resectability with helical CT. Radiology 2001;218:55-60.
31. Valls C, Lopez E, Gumá A, Gil M, Sanchez A, Andia E, et al. Helical CT versus CT arterial portography in the detection of hepatic metastasis of colorectal carcinoma. Am J Roentgenol 1998;170:1341-7.
32. Van Beers BE, Lacrosse M, Jamart J, Grandin C, Gigot JF, Horsmans Y, et al. Detection and segmental location of malignant hepatic tumors: comparison of ferumoxides-enhanced gradient-echo and T2-weighted spin-echo MR imaging. Am J Roentgenol 1997;168:713-7.
33. Vitola JV, Delbelke D, Sandier MP, Campbell MG, Powers TA, Wright JK, et al. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 1996;171:21-6.
34. Vogl TJ, Schwarz W, Blume S, Pietsch M, Shamsi K, Franz M, et al. Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US. Eur Radiol 2003;13:262-72.
35. Ward J, Chen F, Guthrie JA, Wilson D, Lodge JP, Wyatt JI, et al. Hepatic lesion detection after superparamagnetic iron oxide enhancement: comparison of five T2-weighted sequences at 1.0 T by using alternate-free response receiver operating characteristic analyses. Radiology 2000;214:159-6.
36. Ward J, Naik KS, Ashley Guthrie J, Wilson D, Robinson PJ. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Radiology 1999;210:459-66.
37. Ward J, Robinson PJ, Ashley Guthrie J, Downing S, Wilson D, Lodge JP, et al. Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. Radiology 2005;237:170-80.